Ignite Creation Date:
2024-05-05 @ 11:52 AM
Last Modification Date:
2024-10-26 @ 9:15 AM
Study NCT ID:
NCT00158613
Status:
COMPLETED
Last Update Posted:
2021-05-11
First Post:
2005-09-08
Brief Title:
Study of the Treatment of Articular Repair STAR
Sponsor:
Vericel Corporation
Organization:
Vericel Corporation
Study Overview
Official Title:
A Prospective Longitudinal Within-Patient Evaluation of the Effectiveness Durability of Carticel Autologous Cultured Chondrocytes Compared to Non-Carticel Surgical Treatment for Articular Cartilage Defects of the Knee
Status:
COMPLETED
Status Verified Date:
2021-05
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This study is a prospective longitudinal multi-center within patient evaluation of patients with articular cartilage defects of the knee who have had an inadequate response to a prior non-Carticel surgical treatment Patients who met eligibility criteria were enrolled in the study Subsequent to implantation with Carticel patients have follow-up every 6-months up to 48-months
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None